Healthcare Services Group Extends $300M Credit Facility Maturity to 2031
HCSG has more than doubled off its 52-week low of $9.125.
Summary
Healthcare Services Group announced the extension of its $300 million revolving credit facility's maturity date to April 7, 2031, and the addition of a daily SOFR rate option.
Key Events · Financing and Capital Events · HCSG
-
Credit Facility Maturity Extended
The company entered into a Second Amendment to its existing Credit Agreement, extending the maturity date of its $300,000,000 revolving credit facility.
-
New Maturity Date Set
The maturity date for the revolving credit facility has been extended to April 7, 2031, providing long-term financial stability.
-
SOFR Rate Option Added
The amendment also incorporated a daily SOFR rate option into the credit agreement, aligning it with current market practices.
Analysis · HCSG · Industrial Applications And Services
Healthcare Services Group has secured its financial runway by extending the maturity of its existing $300 million revolving credit facility for an additional five years. This amendment to the credit agreement pushes the maturity date out to April 7, 2031, significantly enhancing the company's liquidity profile and reducing near-term refinancing risk. The inclusion of a daily SOFR rate option aligns the facility with current market standards for benchmark interest rates. This extension provides greater financial flexibility and stability, which is a positive signal for investors.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 29.2% of the 1498 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HCSG was trading at $19.19 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $9.13 to $22.98. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.